adverse effects phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (5)
Papers in which this entity is mentioned.
- Specificity, length and luck drive gene rankings in association studies. (2026)
- Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. (2022)
- Polygenic risk scores: from research tools to clinical instruments. (2020)
- Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
- Cancer genome landscapes. (2013)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| adverse effects | phenotype | 19 | 25 |
| side effects | phenotype | 9 | 9 |
| harmful side effects | phenotype | — | — |
| unwanted adverse effects | phenotype | — | — |